Trademark: 87468482
Word
NAVICAN PRECISION CANCER CARE
Status Date
Monday, February 4, 2019
Filing Date
Tuesday, May 30, 2017
Published for Opposition
Tuesday, November 7, 2017
Abandoned Date
Monday, February 4, 2019
1 Assays and reagents for use in genetic research
5 Medical diagnostic reagents and assays for testing of tumor tissue or body fluids
Color is not claimed as a feature of the mark.
"PRECISION CANCER CARE"
Feb 4, 2019
Abandonment Notice E-Mailed - No Use Statement Filed
Feb 4, 2019
Abandonment - No Use Statement Filed
Jul 17, 2018
Corrected Noa E-Mailed
Jul 17, 2018
Notice Of Approval Of Extension Request E-Mailed
Jul 16, 2018
Extension 1 Granted
Jun 29, 2018
Extension 1 Filed
Jul 16, 2018
Divisional Processing Complete
Jun 29, 2018
Divisional Request Received
Jul 16, 2018
Case Assigned To Intent To Use Paralegal
Jun 29, 2018
Teas Request To Divide Received
Jun 29, 2018
Teas Extension Received
Jan 2, 2018
Noa E-Mailed - Sou Required From Applicant
Nov 7, 2017
Official Gazette Publication Confirmation E-Mailed
Nov 7, 2017
Published For Opposition
Oct 18, 2017
Notification Of Notice Of Publication E-Mailed
Oct 1, 2017
Assigned To Lie
Sep 16, 2017
Approved For Pub - Principal Register
Aug 26, 2017
Examiner's Amendment Entered
Aug 26, 2017
Notification Of Examiners Amendment E-Mailed
Aug 26, 2017
Examiners Amendment E-Mailed
Aug 26, 2017
Examiners Amendment -Written
Aug 24, 2017
Examiner's Amendment Entered
Aug 24, 2017
Notification Of Examiners Amendment E-Mailed
Aug 24, 2017
Examiners Amendment E-Mailed
Aug 24, 2017
Examiners Amendment -Written
Aug 17, 2017
Assigned To Examiner
Jun 6, 2017
New Application Office Supplied Data Entered In Tram
Jun 2, 2017
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
